在埃尔德海姆-切斯特病中使用单剂BRAF抑制剂治疗的长期结果
Gaurav Goyal1, Anne S Reiner2, Dana Bossert3
1Division of Hematology and Oncology, Department of Medicine, The University of Alabama at Birmingham, Birmingham, AL.
Blood
|March 7, 2025
概括
BRAF抑制剂对埃尔德海姆-切斯特病的反应率很高,但由于不良事件和生活质量差,导致治疗经常中止.
科学领域:
- 在瘤学瘤学.
- 罕见疾病 罕见疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 埃尔德海姆-切斯特病是一种罕见的非朗格汉斯细胞囊细胞瘤.
- BRAF抑制剂代表了针对埃尔德海姆-切斯特病的向治疗方法.
研究的目的:
- 评估BRAF抑制剂在埃德海姆-切斯特病患者中的疗效和安全性.
- 评估BRAF抑制剂治疗对生活质量和症状负担的影响.
主要方法:
- 对64名接受BRAF抑制剂治疗的埃尔德海姆-切斯特病患者的回顾性分析.
- 平均随访时间为4年.
- 评估反应率,停药率,不良事件,生活质量和症状负担.
主要成果:
- 观察到高达85%的客观响应率.
- 61%的患者经常停止治疗.
- 副作用是停止治疗的主要原因,除了与健康相关的生活质量不佳和高症状负担之外.
结论:
- BRAF抑制剂在埃德海姆-切斯特病中显示出显著的疗效.
- 治疗耐受性和对生活质量的影响仍然是重大挑战.
- 需要进一步的研究来优化BRAF抑制剂治疗和管理埃尔德海姆-切斯特病的不良事件.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K


